Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients

M.H. Liulchuk


556 HIV-infected patients who received antiretroviral therapy (ART) for 6 months were examined for the level of HIV viral load. In 5.92 % of cases we diagnosed viral load above 1,000 RNA copies/ml that indicated virologic failure of ART. On the basis of molecular genetic analysis of the HIV genome, it was found that among the factors influencing the formation of virologic failure of ART in the early stages, one of the most important is noncompliance of antiretroviral drug therapy in patients (low adherence to therapy).


HIV; level of HIV viral load; antiretroviral therapy; virologic efficiency of antiretroviral therapy; mutation of HIV resistance


Бартлет Дж. Клинические аспекты ВИЧ-инфекции: Пер. с англ. / Бартлет Дж., Галант Дж. — М.: EnRus, 2007. — 557 c.

Хоффман К. Лечение ВИЧ-инфекции / Хоффман К., Рокштро Ю.К. — М., 2012. — 736 с.

Клінічний протокол антиретровірусної терапії ВІЛ-інфекції у дорослих та підлітків. Затверджений Наказом МОЗ України № 551 від 12.07.2010 р.

Wagner T.A. Clinical significance of HIV-1 Drug Resistance Mutations / T.A. Wagner, L.M. Frencel // Lab. Med. — 2006. — Vol. 37(9). — P. 554-561.

Castagna A. E-184V. Pilot study to evaluate immunological response to lamivudine monotherapy treatment interruption in failing HIV-1 infected subjects, harbouring the M184V mutation / A. Castagna, A. Danise, E. Carini [et al.] // 15th International Conference on AIDS, 2004, July 11–16. Abst. WeOrB 1286.

Clavel F. HIV drug resistance / Clavel F., Hance A. // N. Engl. J. Med. — 2004. — 350, № 10. — P. 1023-1035.

Paolucci S. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine / Paolucci S., Baldanti F., Campanini G. [et al.] // Antiviral. Res. — 2007. — Vol. 76. — P. 99-103.

Nikolenko G.N. A Novel Molecular Mechanism of Dual Resistance to NRTIs and NNRTIs / G. Nikolenko, K. Delviks-Frankenberry, V. Pathak // J. Virol. — 2010. — Vol. 84. — P. 5238-5249.

Sluis-Cremer N. Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors / N. Sluis-Cremer, G. Tachedjian // Virus Res. — 2008. — Vol. 134. — P. 147-156.

Hang J.Q. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs) / Hang J.Q., Li Y., Yang Y. [et al.] // Biochem. Biophys. Res. Commun. — 2007. — Vol. 352. —

P. 341-350.

Tachedjian G. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation / G. Tachedjian, K.L. Moore [et al.] // FEBS Lett. — 2005. — Vol. 579. — P. 379-384.

Copyright (c) 2016 ACTUAL INFECTOLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2018


   Seo анализ сайта